Altum-Avro Pharma Partnership
Records under this name other than the patents Altum-Avro Pharma Partnership holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 3 of 3 · Back to Altum-Avro Pharma Partnership
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,656,499 | Composition for transdermal and dermal administration of interferon-&agr; Term ended Term ended Nov 10, 2020 · USPTO record | Term ended | Term ended Nov 10, 2020 | USPTO record |
| US 6,165,458 | Composition and method for dermal and transdermal administration of a cytokine Term ended Term ended Dec 18, 2018 · USPTO record | Term ended | Term ended Dec 18, 2018 | USPTO record |
| US 6,444,200 | Composition and method for dermal and transdermal administration of a cytokine Term ended Ended no later than Dec 18, 2018 · USPTO record | Term ended | Ended no later than Dec 18, 2018 | USPTO record |